175 related articles for article (PubMed ID: 34707174)
21. Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors.
Wakimoto H; Kesari S; Farrell CJ; Curry WT; Zaupa C; Aghi M; Kuroda T; Stemmer-Rachamimov A; Shah K; Liu TC; Jeyaretna DS; Debasitis J; Pruszak J; Martuza RL; Rabkin SD
Cancer Res; 2009 Apr; 69(8):3472-81. PubMed ID: 19351838
[TBL] [Abstract][Full Text] [Related]
22. Selective Editing of Herpes Simplex Virus 1 Enables Interferon Induction and Viral Replication That Destroy Malignant Cells.
Liu X; He B
J Virol; 2019 Jan; 93(2):. PubMed ID: 30404809
[TBL] [Abstract][Full Text] [Related]
23. Looking for biomarkers in interferon response pathway to predict response to oncolytic HSV-1 in breast cancer: An ex vivo study.
Nejatipour Z; Teimoori-Toolabi L; Forooshani RS; Barough MS; Farahmand M; Biglari A; Azadmanesh K
Cancer Biomark; 2023; 38(1):37-47. PubMed ID: 37522197
[TBL] [Abstract][Full Text] [Related]
24. Oncolytic herpes simplex virus counteracts the hypoxia-induced modulation of glioblastoma stem-like cells.
Sgubin D; Wakimoto H; Kanai R; Rabkin SD; Martuza RL
Stem Cells Transl Med; 2012 Apr; 1(4):322-32. PubMed ID: 23197811
[TBL] [Abstract][Full Text] [Related]
25. Molecular engineering and validation of an oncolytic herpes simplex virus type 1 transcriptionally targeted to midkine-positive tumors.
Maldonado AR; Klanke C; Jegga AG; Aronow BJ; Mahller YY; Cripe TP; Crombleholme TM
J Gene Med; 2010 Jul; 12(7):613-23. PubMed ID: 20603890
[TBL] [Abstract][Full Text] [Related]
26. A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases.
Chen X; Han J; Chu J; Zhang L; Zhang J; Chen C; Chen L; Wang Y; Wang H; Yi L; Elder JB; Wang QE; He X; Kaur B; Chiocca EA; Yu J
Oncotarget; 2016 May; 7(19):27764-77. PubMed ID: 27050072
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of human MX2 gene suppresses cell proliferation, migration, and invasion via ERK/P38/NF-κB pathway in glioblastoma cells.
Wang H; Guan Q; Nan Y; Ma Q; Zhong Y
J Cell Biochem; 2019 Nov; 120(11):18762-18770. PubMed ID: 31265172
[TBL] [Abstract][Full Text] [Related]
28. Oncolytic HSV-1 suppresses cell invasion through downregulating Sp1 in experimental glioblastoma.
Zhang J; Wang J; Li M; Su X; Tian Y; Wang P; Zhou X; Jin G; Liu F
Cell Signal; 2023 Mar; 103():110581. PubMed ID: 36572188
[TBL] [Abstract][Full Text] [Related]
29. Production of bioactive soluble interleukin-15 in complex with interleukin-15 receptor alpha from a conditionally-replicating oncolytic HSV-1.
Gaston DC; Odom CI; Li L; Markert JM; Roth JC; Cassady KA; Whitley RJ; Parker JN
PLoS One; 2013; 8(11):e81768. PubMed ID: 24312353
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of human cancer cells infected by an oncolytic HSV-1 reveals multiple upregulated cellular genes and a role for SOCS1 in virus replication.
Mahller YY; Sakthivel B; Baird WH; Aronow BJ; Hsu YH; Cripe TP; Mehrian-Shai R
Cancer Gene Ther; 2008 Nov; 15(11):733-41. PubMed ID: 18551144
[TBL] [Abstract][Full Text] [Related]
31. Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors.
Tamura K; Wakimoto H; Agarwal AS; Rabkin SD; Bhere D; Martuza RL; Kuroda T; Kasmieh R; Shah K
Mol Ther; 2013 Jan; 21(1):68-77. PubMed ID: 22929661
[TBL] [Abstract][Full Text] [Related]
32. Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells.
Kim T; Pazhoor S; Bao M; Zhang Z; Hanabuchi S; Facchinetti V; Bover L; Plumas J; Chaperot L; Qin J; Liu YJ
Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15181-6. PubMed ID: 20696886
[TBL] [Abstract][Full Text] [Related]
33. Histone deacetylase inhibitors improve the replication of oncolytic herpes simplex virus in breast cancer cells.
Cody JJ; Markert JM; Hurst DR
PLoS One; 2014; 9(3):e92919. PubMed ID: 24651853
[TBL] [Abstract][Full Text] [Related]
34. Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma.
Ning J; Wakimoto H; Peters C; Martuza RL; Rabkin SD
J Natl Cancer Inst; 2017 Mar; 109(3):1-13. PubMed ID: 28376211
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus.
Jahan N; Lee JM; Shah K; Wakimoto H
Int J Cancer; 2017 Oct; 141(8):1671-1681. PubMed ID: 28567859
[TBL] [Abstract][Full Text] [Related]
36. Identification of Rab27a as a host factor for oncolytic herpes virus susceptibility to tumor cells.
Zhou X; Zhao J; Wu Y; Wang L; Ji D; Chen X; Ren P; Zhou GG
Virus Res; 2021 Jul; 299():198425. PubMed ID: 33905773
[TBL] [Abstract][Full Text] [Related]
37. Multiple strategies to improve the therapeutic efficacy of oncolytic herpes simplex virus in the treatment of glioblastoma.
Zhou Z; Tian J; Zhang W; Xiang W; Ming Y; Chen L; Zhou J
Oncol Lett; 2021 Jul; 22(1):510. PubMed ID: 33986870
[TBL] [Abstract][Full Text] [Related]
38. MX2 Viral Substrate Breadth and Inhibitory Activity Are Regulated by Protein Phosphorylation.
Betancor G; Bangham M; Jeon JK; Shah K; Lynham S; Jimenez-Guardeño JM; Malim MH
mBio; 2022 Aug; 13(4):e0171422. PubMed ID: 35880880
[TBL] [Abstract][Full Text] [Related]
39. The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferon.
Alvarez-Breckenridge CA; Yu J; Price R; Wei M; Wang Y; Nowicki MO; Ha YP; Bergin S; Hwang C; Fernandez SA; Kaur B; Caligiuri MA; Chiocca EA
J Virol; 2012 Apr; 86(8):4566-77. PubMed ID: 22318143
[TBL] [Abstract][Full Text] [Related]
40. Oncolytic herpes simplex virus and immunotherapy.
Ma W; He H; Wang H
BMC Immunol; 2018 Dec; 19(1):40. PubMed ID: 30563466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
